Literature DB >> 20495575

TGFbeta signalling: a complex web in cancer progression.

Hiroaki Ikushima1, Kohei Miyazono.   

Abstract

The distortion of growth factor signalling is the most important prerequisite in tumour progression. Transforming growth factor-beta (TGFbeta) signalling regulates tumour progression by a tumour cell-autonomous mechanism or through tumour-stroma interaction, and has either a tumour-suppressing or tumour-promoting function depending on cellular context. Such inherent complexity of TGFbeta signalling results in arduous, but promising, assignments for developing therapeutic strategies against malignant tumours. As numerous cellular context-dependent factors tightly maintain the balance of TGFbeta signalling and contribute to the regulation of TGFbeta-induced cell responses, in this Review we discuss how they maintain the balance of TGFbeta signalling and how their collapse leads to tumour progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495575     DOI: 10.1038/nrc2853

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  128 in total

Review 1.  Two major Smad pathways in TGF-beta superfamily signalling.

Authors:  Keiji Miyazawa; Masahiko Shinozaki; Takane Hara; Toshio Furuya; Kohei Miyazono
Journal:  Genes Cells       Date:  2002-12       Impact factor: 1.891

2.  Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.

Authors:  Jennifer A Tuxhorn; Stephanie J McAlhany; Feng Yang; Truong D Dang; David R Rowley
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

3.  Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.

Authors:  Y Hasegawa; S Takanashi; Y Kanehira; T Tsushima; T Imai; K Okumura
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

4.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

Authors:  Alejandra Bruna; Rachel S Darken; Federico Rojo; Alberto Ocaña; Silvia Peñuelas; Alexandra Arias; Raquel Paris; Avelina Tortosa; Jaume Mora; Jose Baselga; Joan Seoane
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

5.  TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

Authors:  Kazuhito Naka; Takayuki Hoshii; Teruyuki Muraguchi; Yuko Tadokoro; Takako Ooshio; Yukio Kondo; Shinji Nakao; Noboru Motoyama; Atsushi Hirao
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

6.  Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.

Authors:  Changgong Li; Nian-Ling Zhu; Rosemarie C Tan; Philip L Ballard; Rik Derynck; Parviz Minoo
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

7.  Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.

Authors:  B I Dalal; P A Keown; A H Greenberg
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.

Authors:  T Ryan Heider; Suzanne Lyman; Robert Schoonhoven; Kevin E Behrns
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

9.  SnoN functions as a tumour suppressor by inducing premature senescence.

Authors:  Deng Pan; Qingwei Zhu; Kunxin Luo
Journal:  EMBO J       Date:  2009-09-10       Impact factor: 11.598

10.  BCL6 represses Smad signaling in transforming growth factor-beta resistance.

Authors:  Degang Wang; Jianyin Long; Fangyan Dai; Min Liang; Xin-Hua Feng; Xia Lin
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

View more
  489 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

2.  Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.

Authors:  Geeta Upadhyay; Yuzhi Yin; Hongyan Yuan; Xin Li; Rik Derynck; Robert I Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

4.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

5.  Zyxin is a transforming growth factor-β (TGF-β)/Smad3 target gene that regulates lung cancer cell motility via integrin α5β1.

Authors:  Nikica Mise; Rajkumar Savai; Haiying Yu; Johannes Schwarz; Naftali Kaminski; Oliver Eickelberg
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 6.  Targeting the tumor stroma in hepatocellular carcinoma.

Authors:  Femke Heindryckx; Pär Gerwins
Journal:  World J Hepatol       Date:  2015-02-27

Review 7.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

8.  TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells.

Authors:  Sarah S Donatelli; Jun-Min Zhou; Danielle L Gilvary; Erika A Eksioglu; Xianghong Chen; W Douglas Cress; Eric B Haura; Matthew B Schabath; Domenico Coppola; Sheng Wei; Julie Y Djeu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

9.  TGFβ splicing and canonical pathway activation in high-grade serous carcinoma.

Authors:  Neriya Gutgold; Ben Davidson; Liora Jacobs Catane; Arild Holth; Ellen Hellesylt; Claes G Tropé; Anne Dørum; Reuven Reich
Journal:  Virchows Arch       Date:  2017-04-21       Impact factor: 4.064

10.  TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Stephen Safe
Journal:  Mol Cancer Res       Date:  2018-08-02       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.